19 studies found for:    "Hemoglobin SC disease"
Show Display Options
Rank Status Study
1 Terminated Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate
Condition: HEMOGLOBIN SC DISEASE
Interventions: Drug: Mg Pidolate;   Drug: Placebo
2 Recruiting Treatment of Adult Patients With Hemoglobin SC Disease (SCYTHE)
Condition: Hemoglobin SC Disease
Intervention: Drug: Hydroxyurea
3 Recruiting Treatment of Hemoglobin SC Disease
Condition: Hemoglobin SC Disease
Intervention: Drug: hydroxyurea
4 Terminated
Has Results
Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease
Condition: Hemoglobin SC Disease
Interventions: Drug: Hydroxyurea;   Drug: Magnesium Pidolate;   Other: Placebo Pills and Placebo Liquid
5 Withdrawn Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
Conditions: Anemia, Sickle Cell;   Sickle Cell Anemia;   Sickle Cell Disease;   Sickle Cell Disorders;   Hemoglobin SC Disease;   Sickle Cell Hemoglobin C Disease
Interventions: Drug: MP4CO;   Drug: Sodium chloride solution
6 Completed Safety Study of MP4CO in Adult Sickle Cell Patients
Conditions: Anemia, Sickle Cell;   Sickle Cell Anemia;   Sickle Cell Disease;   Sickle Cell Disorders;   Hemoglobin SC Disease;   Sickle Cell Hemoglobin C Disease
Interventions: Drug: MP4CO;   Drug: Sodium chloride solution
7 Active, not recruiting Parent Educational Program for Children With Sickle Cell Disease
Conditions: Hemoglobin SC Disease;   Anemia, Sickle Cell
Intervention: Behavioral: Parent Educational Support
8 Completed Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease
Conditions: Anemia, Sickle Cell;   Hemoglobin SC Disease
Interventions: Behavioral: PAINReportIt;   Behavioral: PAINUCope;   Behavioral: PAINConsultN
9 Recruiting Natural History of Sickle Cell Disease and Other Hemolytic Disorders
Conditions: Hemoglobin SC Disease;   Hematologic Diseases;   Sickle Cell Anemia;   Hemolytic Anemia
Intervention:
10 Terminated Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia
Conditions: Hemoglobinopathies;   Anemia, Sickle Cell;   Hemoglobin SC Disease;   Thalassemia;   Thalassemia Major
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: FK506;   Drug: Prednisone
11 Completed A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders
Conditions: Hemoglobin SC Disease;   Sickle Cell Anemia
Intervention: Drug: Recombinant-methionyl human stem cell factor
12 Terminated Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP
Conditions: Sickle Cell Disease;   Hemoglobin SC
Interventions: Drug: Busulfan;   Biological: Campath 1H;   Drug: Cyclophosphamide and MESNA
13 Terminated
Has Results
Treatment of Sickle Cell Anemia With Stem Cell Transplant
Conditions: Sickle Cell Anemia;   Sickle Cell-hemoglobin C Disease;   Sickle Cell-β0-thalassemia
Interventions: Drug: Fludarabine;   Drug: Cytarabine;   Device: Cellular Infusions;   Radiation: Total Body Irradiation;   Drug: Cyclophosphamide;   Drug: Bortezomib;   Drug: Rituximab;   Procedure: Plasmapheresis
14 Completed Evaluation of a Training Program for Homozygous Sickle Cell Disease Patients
Conditions: Sickle Cell Hemoglobin C Disease;   Hemoglobin S Disease
Intervention: Other: Training Program
15 Active, not recruiting Decision Aid for Therapeutic Options In Sickle Cell Disease
Conditions: Sickle Cell Disease;   Sickle Cell Anemia;   Hemoglobin SS;   Hemoglobin SC;   Hemoglobin Beta Thalassemia
Interventions: Other: Decision Aid;   Other: Standard Practice
16 Unknown  Far Infrared Radiation for Sickle Cell Pain Management
Condition: Anemia, Sickle Cell
Intervention: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
17 Terminated Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
Conditions: Sickle Cell Anemia;   Hemoglobinopathy;   Thalassemia
Interventions: Drug: Campath -1H;   Drug: Dilantin;   Drug: Busulfan;   Drug: Cyclophosphamide
18 Not yet recruiting Sickle Cell Omega-3 Treatment Trial (SCOT Trial)
Condition: Sickle Cell Disease
Interventions: Drug: SC411;   Drug: Placebo
19 Completed
Has Results
Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies
Conditions: Hemoglobinopathies;   Sickle Cell Disease;   Thalassemia
Interventions: Drug: Busulfex;   Drug: Fludarabine;   Drug: Alemtuzumab;   Procedure: Stem Cell Transfusion

Indicates status has not been verified in more than two years